background
sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
novel
coronaviru
sarscov
sar
caus
outbreak
world
individu
infect
death
toll
region
around
world
specif
humor
respons
viral
infect
remain
unclear
object
analys
antigen
sarscov
genom
identifi
potenti
antigen
epitop
structur
protein
method
potenti
antigen
epitop
identifi
structur
protein
nucleocapsid
membran
spike
small
envelop
protein
hypothet
protein
specif
sarscov
peptid
chip
platform
creat
profil
antibodi
epitop
investig
differ
sar
patient
sera
obtain
day
onset
ill
serial
sera
five
addit
patient
also
studi
result
epitop
nterminu
membran
protein
cterminu
nucleocapsid
protein
elicit
strong
antibodi
respons
epitop
spike
protein
moder
immunogen
effect
persist
antibodi
also
detect
put
protein
notic
ctermini
n
epidem
outbreak
sever
acut
respiratori
syndrom
sar
haunt
region
world
novemb
juli
epidem
individu
infect
cumul
mortal
clinic
patholog
featur
sar
studi
extens
specif
humor
respons
protein
caus
agent
sarsa
new
coronaviru
sarscov
howev
poorli
understood
sarscov
envelop
posit
strand
rna
viru
viral
genom
kb
long
contain
open
read
frame
orf
end
genom
two
larg
orf
encod
replic
protein
present
two
protein
rel
higher
homolog
member
coronaviru
end
gene
structur
protein
envelop
membran
nucleocapsid
spike
well
hypothet
protein
latter
group
hypothet
protein
similar
known
mammalian
viral
protein
may
specif
target
treatment
vaccin
develop
studi
analys
end
sarscov
genom
identifi
specif
uniqu
potenti
antigen
site
size
amino
acid
structur
hypothet
protein
use
peptid
chip
platform
determin
antibodi
profil
peptid
sera
sar
patient
differ
time
point
chemic
purchas
sigma
st
loui
missouri
usa
unless
specifi
peptid
synthesi
carri
abgent
inc
keyhol
limpet
haemocyanin
klh
conjug
kit
purchas
pierc
biotechnolog
rockford
illinoi
usa
goat
fc
antihuman
igg
f
ab
obtain
pepsindigest
goat
igg
react
specif
fc
fragment
human
igg
goat
antihuman
igm
fmc
igg
react
portion
human
igm
heavi
chain
purchas
jackson
laboratori
bar
harbor
main
usa
alexa
alexa
protein
label
kit
purchas
molecular
probe
eugen
oregon
usa
studi
antibodi
sar
patient
approv
local
ethic
committe
clinic
diagnosi
sar
follow
case
definit
criteria
fifti
nine
serum
specimen
differ
patient
collect
day
onset
ill
obtain
singl
hospit
one
serum
use
multipl
specimen
obtain
patient
one
singl
day
patient
treat
steroid
regim
develop
time
epidem
antigen
peptid
sarscov
genom
antigen
epitop
put
orf
sarscov
genbank
access
evalu
silico
use
clone
manag
scientif
educ
softwar
cari
north
carolina
usa
peptid
companion
csp
pharmaceut
inc
san
diego
california
usa
ds
gene
accelri
san
diego
california
usa
follow
criteria
protein
homolog
redund
sequenc
mostli
blast
human
mous
sequenc
refseq
genbank
protein
hydrophil
protein
flexibl
protein
structurebturn
bsheet
ahelix
solvent
access
charg
balanc
protein
stabil
instabl
index
protein
modif
amino
acid
composit
peptid
synthesi
rule
coupl
effici
peptid
compar
publish
data
coronaviru
cov
human
group
group
cov
bovinecov
porcinecov
felinecov
caninecov
sarscov
specif
sequenc
select
genom
locat
sequenc
peptid
select
shown
fig
tabl
respect
peptid
chip
platform
one
milligram
peptid
conjug
mg
klh
carrier
protein
purifi
gel
filtrat
chromatographi
conjug
peptid
spot
onto
inhous
develop
multichamb
fast
slide
array
two
cartesian
microsi
fit
telechem
pin
neg
control
mgml
bovin
serum
albumin
mgml
klh
optimum
concentr
peptid
tabl
determin
empir
use
serial
dilut
conjug
peptid
mgml
mgml
dilut
test
serum
ml
block
buffer
incub
minut
peptid
chip
block
nonfat
milk
mm
trisbuff
salin
ph
one
hour
wash
three
time
ml
tb
buffer
mm
tri
ph
reaction
label
simultan
alexa
goat
antihuman
igg
dilut
block
buffer
alexa
goat
antihuman
igm
dilut
block
buffer
minut
fluoresc
imag
acquir
use
laser
scanner
coupl
scanarray
softwar
perkin
elmer
norwalk
connecticut
usa
quantarray
softwar
perkin
elmer
data
experi
analys
signal
normalis
normal
control
sampl
neg
control
data
analysi
model
visualis
undertaken
use
avadi
softwar
strand
genom
bangalor
india
refer
genom
sequenc
sarscov
examin
antigen
silico
among
potenti
epitop
uniqu
sarscov
select
analys
least
one
potenti
antigen
site
identifi
structur
protein
hypothet
protein
fig
tabl
correspond
peptid
synthesis
immobilis
membran
coat
slide
creat
peptid
chip
platform
sera
sar
patient
obtain
differ
patient
day
onset
ill
studi
use
peptid
chip
platform
simultan
record
level
antibodi
epitop
igm
igg
specif
epitop
measur
display
array
detect
patient
sera
show
differ
tempor
sequenc
end
sarscov
genom
specif
dna
segment
antigen
epitop
particularli
concentr
averag
igm
igg
respons
day
epitop
examin
fig
upper
lower
panel
respect
control
popul
consist
nonsar
patient
time
epidem
nterminu
epitop
membran
protein
cterminu
epitop
nucleocapsid
protein
n
elicit
mark
igm
igg
respons
multipl
epitop
spike
protein
evok
humor
respons
rel
weaker
antibodi
hypothet
protein
also
detect
patient
low
nonspecif
antibodi
respons
epitop
protein
n
protein
envelop
e
protein
hypothet
hypothet
well
hierarch
cluster
analys
data
show
singl
dendrogram
organis
igm
igg
respons
fig
panel
b
respect
signal
epitop
repres
descend
order
right
side
dendrogram
segreg
major
subgroup
observ
result
suggest
homogen
antibodi
reaction
epitop
minor
subgroup
howev
detect
epitop
n
protein
form
subclust
igg
respons
fig
epitop
protein
n
protein
e
protein
hypothet
protein
hypothet
protein
group
togeth
left
end
cluster
owe
common
low
mean
antibodi
respons
epitop
see
previou
section
fig
antibodi
respons
immunogen
site
appear
biphas
phenomenon
better
visualis
plot
convent
time
cours
antibodi
respons
epitop
fig
trough
antibodi
respons
appear
day
onset
ill
odd
ratio
posit
igm
igg
respons
individu
peptid
time
interv
confirm
impress
graphic
present
posit
valu
igm
igg
list
tabl
respect
heterogen
humor
respons
differ
individu
seen
longitudin
studi
igm
igg
five
addit
sar
patient
e
serial
sampl
serum
avail
fig
major
organis
dendrogram
individu
patient
similar
main
dataset
fig
presenc
antibodi
respons
one
epitop
predict
occurr
magnitud
respons
one
epitop
bear
anoth
reactiv
epitop
underli
mechan
differ
remain
unclear
studi
demonstr
humor
respons
epitop
defin
oligopeptid
specif
sarscov
genom
antibodi
conform
complex
structur
primari
amino
acid
sequenc
may
captur
peptid
chip
consider
cost
sarscov
specif
peptid
select
studi
epitop
identifi
therefor
portion
antigen
site
sarscov
report
strong
humor
respons
membran
nucleocapsid
n
protein
put
hypothet
protein
notic
also
shown
import
humor
respons
sarscov
infect
n
protein
strongest
immunoreact
among
structur
protein
abund
protein
sarscov
may
explain
high
immunoreact
determin
immunodomin
epitop
n
protein
specif
sarscov
eight
epitop
cand
ntermini
studi
cterminu
epitop
show
similar
signal
profil
signific
increas
intens
first
day
second
peak
day
fig
consist
studi
antibodi
whole
n
protein
produc
sar
patient
appear
earli
stage
diseas
epitop
cterminu
n
produc
greater
humor
respons
nterminu
epitop
overlap
five
amino
acid
eightto
excess
signal
detect
nterminu
n
protein
less
well
investig
data
suggest
small
regiondefin
exclud
antigen
humor
respons
appear
late
cours
infect
spike
protein
sarscov
type
transmembran
glycoprotein
respons
viru
bind
fusion
residu
amino
acid
protein
bound
specif
function
receptor
angiotensin
convert
enzym
studi
seven
epitop
design
along
nto
ctermini
protein
averag
fluoresc
unit
moder
signal
observ
middl
amino
acid
cterminu
amino
acid
unlik
n
protein
consist
earlier
find
reactiv
whole
protein
low
signal
detect
earli
stage
howev
signal
increas
exponenti
day
among
three
epitop
appear
strongest
immunodomin
antigen
protein
support
earlier
report
finer
resolut
antigen
detect
current
studi
cterminu
novel
view
import
protein
sarscov
infect
explor
area
import
membran
protein
rel
small
viral
structur
protein
two
potenti
epitop
identifi
protein
strong
epitop
found
nterminu
increas
respons
compar
cterminu
theoret
sequenc
analysi
predict
singl
weak
epitop
site
protein
studi
show
antibodi
fact
common
among
subject
elicit
strong
persist
respons
humor
respons
protein
may
use
diagnost
test
surveil
whether
antibodi
protein
convey
protect
futur
sarscov
infect
await
clarif
biolog
basi
variabl
antibodi
respons
differ
epitop
sarscov
individu
patient
clear
sever
line
evid
suggest
influenc
host
genet
factor
sar
human
leucocyt
antigen
hla
class
b
class
ii
associ
suscept
sar
local
hla
class
n
specif
antigen
site
may
also
import
vaccin
develop
new
fatal
infecti
diseas
b
associ
sever
sar
cohort
taiwanes
differ
hla
phenotyp
perhap
immun
respons
might
key
pathogenesi
sar
therefor
import
correl
hla
phenotyp
patient
explor
genet
basi
observ
variabl
antibodi
respons
identifi
epitop
sarscov
differ
structur
protein
put
protein
elicit
natur
humor
respons
owe
rel
simplic
product
oligopeptid
compar
whole
protein
sarscov
specif
antigen
site
like
valuabl
design
bedsid
diagnost
test
epitop
may
also
import
develop
vaccin
new
fatal
human
infecti
diseas
